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Among the hallmark phenotypes reported in individuals with
fragile X syndrome (FXS) are deﬁcits in attentional function,
inhibitory control, and cognitive ﬂexibility, a set of cognitive skills
thought to be associatedwith the prefrontal cortex (PFC). However,
despite substantial clinical research into these core deﬁcits, the PFC
has received surprisingly little attention in preclinical research,
particularly in animal models of FXS. In this study, we sought to
investigate the molecular, cellular, and behavioral consequences of
the loss of the fragile X mental retardation protein in the PFC of
Fmr1 KO mice, a mouse model of FXS. We identify a robust cogni-
tive impairment in these mice that may be related to the deﬁcits
in cognitive ﬂexibility observed in individuals with FXS. In addition,
we report that levels of proteins involved in synaptic func-
tion, including the NMDA receptor subunits NR1, NR2A, and
NR2B; the scaffolding proteins PSD-95 and SAPAP3; and the plastic-
ity-related gene Arc, are decreased in the prefrontal cortex of Fmr1
KO mice and are partly correlated with behavioral performance.
Finally, we report that expression of c-Fos, a marker of neuronal
activity, is decreased in the PFC of Fmr1 KO mice. Together, these
data suggest that Fmr1 KO mice may represent a valuable animal
model for the PFC-associated molecular, cellular, and behavioral
abnormalities in FXS and that this model may be useful for testing
the efﬁcacy of therapeutic strategies aimed at treating the cogni-
tive impairments in FXS.
behavior | operant | orbitofrontal | NMDA receptor
Fragile X syndrome (FXS) is the most common form ofinherited mental retardation and a leading known cause of
autism (1). It is caused by loss of the Fmr1 gene product fragile X
mental retardation protein (FMRP), an mRNA-binding protein
involved in translational regulation (2, 3). FMRP is thought to
repress the synthesis of proteins required for protein synthesis-
dependent synaptic plasticity (4, 5). In FXS, the absence of
FMRP is hypothesized to result in unrestricted synthesis of
plasticity-related proteins (6, 7), impairing the ability of synapses
to appropriately undergo plasticity in an activity-dependent and
stimulus-speciﬁc manner. In support of this hypothesis, mice with
a deletion in the Fmr1 gene (Fmr1 KO mice) display aberrant
forms of plasticity (4) and an increase in immature dendritic
spines that presumably reﬂects an abnormal synaptic connectiv-
ity (8). Together, these synaptic alterations are thought to un-
derlie the cognitive and behavioral phenotypes that are the
hallmark features of FXS.
Among the most common symptoms reported in FXS are
deﬁcits in attentional function, inhibitory control, and cognitive
ﬂexibility (9), cognitive skills that have all been linked to the
prefrontal cortex (PFC) and associated fronto-striatal networks
(10, 11). Anatomical and imaging studies of individuals with FXS
have identiﬁed structural alterations in PFC, and numerous
fMRI studies have shown aberrant patterns of neural activity in
fronto-striatal pathways during cognitive tasks (12). Together, all
of these results suggest that the fronto-striatal network is one of
the key brain systems impaired in FXS (9).
Despite extensive clinical research into this core deﬁcit in
FXS, only a few studies have speciﬁcally addressed the role of
the PFC and related cognitive functions in animal models of
FXS. In the PFC of Fmr1 KO mice, abnormalities were detected
in the density of dendritic spines (13), the induction of spike-
timing–dependent plasticity (14), and the response to dopami-
nergic signaling (15–17), and subtle cognitive impairments in
these mice have also been reported (18–20). However, sub-
stantial further research will be crucial both in elucidating the
molecular mechanisms by which loss of FMRP expression affects
PFC function in FXS and in developing animal models suitable
for screening potential drug treatments that target the core
cognitive deﬁcits. In the current study, we address this issue by
developing a behavioral paradigm that identiﬁes a robust cog-
nitive impairment in the Fmr1 KO mice, as well as by in-
vestigating the accompanying molecular and cellular alterations
in the PFC of these mice.
Results
Fmr1 KO Mice Are Impaired in the Acquisition of a Visuospatial
Discrimination Task. A major aim of our study was to identify
behavioral deﬁcits in Fmr1 KO mice that represent a model for
the core cognitive phenotypes observed in FXS. To this end, we
ﬁrst tested mice in a behavioral task used to assess sustained
attention and inhibitory control in rodents, the ﬁve-choice serial
reaction time task (5CSRTT) (21). This paradigm uses an op-
erant test chamber equipped with ﬁve nose-poke holes, i.e.,
apertures that can detect a nose-poke response by the mouse,
and a food magazine into which a food reward can be delivered.
In our experiment, Fmr1 KO mice and wild-type (WT) litter-
mates were ﬁrst trained to perform a nose-poke response in an
illuminated aperture to obtain a food response (see SI Materials
and Methods for details of the training phases), and they were
then subjected to two ﬁnal tests, one to measure sustained at-
tention and one to measure inhibitory control (SI Materials and
Methods). We found that Fmr1 KO mice did not differ from their
WT littermates in either of the two ﬁnal tests, suggesting that,
under our conditions, these mice do not display deﬁcits in sus-
tained attention or inhibitory control (Fig. S1 A and B). In-
terestingly, however, we observed a signiﬁcant and very selective
deﬁcit in one of the pretest training phases (Fig. S1C; SI Mate-
rials and Methods), and we therefore decided to further pursue
this impairment.
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To this end, we trained mice on a shortened paradigm in-
cluding only the ﬁrst two training phases of the original 5CSRTT
(Fig. 1A). In the ﬁrst phase, all ﬁve apertures were illuminated
and active, and a nose-poke response in any of the apertures
resulted in the delivery of a food reward. Fmr1 KO mice showed
no signiﬁcant difference in the number of days taken to acquire
this task (Fig. 1B; one-way ANOVA for genotype, F1,24 < 1),
suggesting that they are not impaired in the acquisition of an
appetitive instrumental response under the current experimental
conditions. In the second phase, only one of the ﬁve apertures was
illuminated and active, and only a response in this aperture was
rewarded. Fmr1 KO mice took signiﬁcantly longer to acquire this
phase of the task (Fig. 1B; one-way ANOVA for genotype, F1,22 =
7.11, P < 0.05), and they made signiﬁcantly more errors than WT
mice (Fig. 1C; one-way ANOVA for genotype, F1,22 = 12.52, P <
0.01). Further analysis of this phase revealed that Fmr1 KO mice
did not differ signiﬁcantly from WT littermates in the number of
trials completed per session, although there was a trend toward
a genotype × training day interaction (Fig. 1D; repeated measures
ANOVA for genotype, F1,24 < 1; genotype × training day in-
teraction, F9,216 = 1.67, P = 0.1). However, they made signiﬁ-
cantly more errors per trial in the ﬁrst days of training (Fig. 1E;
repeated measures ANOVA for genotype, F1,24 = 14.3, P< 0.001;
genotype × day interaction, F9,216 = 8.76, P < 0.001). These data
suggest that Fmr1 KO mice are impaired in the acquisition of
a visuospatial discrimination task, but not in the performance of
the visuospatial discrimination itself, as indicated by the fact that
both groups reach equal levels of performance by the end of a 10-d
training period (Fig. 1E; post hoc analysis for day 10, P = 0.824).
Fmr1 KO Mice Display a Stronger Spatial Preference in Responding.
To further explore the cause of this impairment, we investigated
the pattern of nose-poke responses by spatial location, analyzing
each of the ﬁve apertures individually. On the basis of the total
number of responses made in the last 2 d of phase 1 (i.e., the
days in which the mouse was considered to have acquired the
task), the apertures were ranked by preference for each in-
dividual mouse. Both genotypes showed a spatial preference for
certain apertures over others in phase 1 (Fig. 1F; main effect of
aperture, F4,72 = 58.82, P < 0.001). However, Fmr1 KO mice
showed a stronger spatial preference; i.e., they made signiﬁcantly
more responses in the most preferred aperture than did the WT
mice (Fig. 1F; main effect of genotype, F1,18 < 1; genotype ×
aperture interaction, F4,72 = 7.06, P < 0.001; post hoc analysis for
the most preferred aperture, P < 0.05). Using the same prefer-
ence ranking, the number of errors to criterion in phase 2 was
assessed for each nose-poke aperture (Fig. 1G; main effect of
genotype, F1,18 = 10.7, P < 0.005; genotype × aperture in-
teraction, F4,72 = 4.06, P < 0.01). WT mice made similar num-
bers of errors to criterion in each aperture, suggesting that the
slight spatial preference displayed in phase 1 did not inﬂuence
performance in phase 2. Fmr1 KO mice, on the other hand,
made signiﬁcantly more errors in the previously preferred
apertures. These data suggest that a lack of cognitive ﬂexibility in
the Fmr1 KO mice may contribute to the delay in acquisition of
the visuospatial discrimination task described here.
Behavioral Impairments Are Accompanied by Decreases in Synaptic
Markers in Orbitofrontal Cortex and Medial Prefrontal Cortex of Fmr1
KO Mice. A central question in FXS is how loss of translational
regulation by FMRP affects the molecular composition of the
synapse, and how this in turn results in the cognitive impairments
seen in FXS. To begin to address this issue, we investigated
whether expression of synaptic proteins was altered in the PFC
of the same Fmr1 KO mice that had undergone behavioral
training. We isolated two subregions of PFC (Fig. 2A)—the
orbitofrontal cortex (OFC) and the medial prefrontal cortex
(mPFC)—both of which are required for various aspects of be-
havioral ﬂexibility in rodents (22–24). The global proﬁle of
protein expression in Fmr1 KO mice was similar to that of WT
mice, as assessed by a total protein stain (Fig. 2B). Interestingly,
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Fig. 1. Fmr1 KO mice are impaired in the acquisition of a visuospatial dis-
crimination task. (A) Schematic illustrating the design of the behavioral task,
which consists of three components: magazine training (“Mag”) to habitu-
ate the mice to the operant conditioning chambers; phase 1, in which all ﬁve
nose-poke (“NP”) apertures are active (“correct response”); and phase 2, in
which only one nose-poke aperture is active and the other four are inactive
(“error”). Mice were trained on each of the two acquisition phases until their
performance reached a predeﬁned criterion (“crit”; see Materials and
Methods for details). (B) Number of days taken to reach criterion on each
phase. Fmr1 KO mice were not impaired in the acquisition of phase 1, but
they required signiﬁcantly more time than their WT littermates to reach
criterion on phase 2 (one-way ANOVA, P < 0.05, n = 12). (C) Cumulative
number of errors to criterion. Fmr1 KO mice made signiﬁcantly more errors
than their WT littermates in phase 2 (one-way ANOVA, P < 0.01, n = 12). This
measure is not applicable for phase 1 because all responses were considered
correct and errors were not possible. (D) Number of trials completed per day
during phase 2. There was no signiﬁcant difference between genotypes as
assessed by repeated measures ANOVA, although post hoc analysis revealed
a small but signiﬁcant decrease in the number of trials completed by KO on
the ﬁrst day of phase 2. (E) Average number of errors made per trial on each
day of phase 2. Fmr1 KO mice made signiﬁcantly more errors per trial on the
ﬁrst 6 d of phase 2 (repeated measures ANOVA for genotype, P < 0.001;
genotype × day interaction, P < 0.001, n = 10). (F) Total number of responses
per nose-poke aperture in the last 2 d of phase 1, ranked by preference for
each mouse. Fmr1 KO mice show a signiﬁcantly stronger preference for their
most preferred aperture (repeated measures ANOVA, genotype × aperture
interaction, P < 0.001, n = 10). (G) Total number of errors to criterion per
nose-poke aperture in phase 2, ranked by the preference shown in phase 1.
Fmr1 KO mice made signiﬁcantly more errors in their most preferred aper-
tures (repeated measures ANOVA genotype × aperture interaction, P < 0.01,
n = 13). Error bars represent SEM; *P < 0.05, **P < 0.01.
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however, a number of proteins associated with postsynaptic
function were signiﬁcantly decreased in both OFC (Fig. 2 C and
D; Table 1) and mPFC (Fig. 2E; Table 1) of Fmr1 KO mice,
whereas none of the proteins examined here were signiﬁcantly
increased in the absence of FMRP. The most robust and con-
sistent decreases were those in the NMDA receptor subunits
NR1, NR2A, and NR2B, the postsynaptic scaffolding proteins
SAPAP3 and PSD-95, and the plasticity-related molecule Arc
(Table 1). In contrast, no signiﬁcant changes were observed in
another synaptic marker, SNAP25, or in the cytoplasmic protein
actin, suggesting that the decreases may be speciﬁc for a subset
of components of the postsynaptic apparatus. Together, these
data suggest that there is a decrease in either the number or the
complexity of postsynaptic terminals in the OFC and mPFC of
Fmr1 KO mice, which in turn may be relevant for the cognitive
impairment described above.
Behavioral Performance Correlates with Levels of NR2A and NR2B in
mPFC. To further investigate which of the above molecular alter-
ations may be most relevant for the cognitive impairment in the
Fmr1 KO mice, we analyzed whether expression levels of any of
the postsynaptic proteins were directly correlated with behavioral
performance (Fig. 3). This analysis revealed that levels of NR2A
in mPFC, but not in OFC, were negatively correlated with the
number of days taken to reach criterion (Fig. 3A; r = −0.59, P <
0.001), indicating that the mice with the lowest levels of these
subunits also took the longest to acquire the visuospatial dis-
crimination task. A similar, albeit substantially weaker, correlation
was observed for NR2B in mPFC (Fig. 3B; r = −0.32, P < 0.05).
Interestingly, levels of NR1 were not correlated with behavioral
performance in either OFC or mPFC (Fig. 3C; r= −0.1, P= 0.5).
It therefore appears that the decreases in NR2A and NR2B levels
in the mPFC may be particularly important for impairment in the
acquisition of the current visuospatial discrimination task.
Synaptic Proteins Are Altered in Behaviorally Naive Fmr1 KO Mice.
Two potential explanations may account for the relationship be-
tween synaptic protein levels and behavioral performance: The
molecular alterations may have preceded the cognitive deﬁcit or,
conversely, they may have occurred as a consequence of the be-
havioral training. To distinguish between these possibilities, we
isolated tissue from OFC and mPFC of WT and Fmr1 KO mice
that were the same age as the previous subjects, but that had not
received any behavioral training or handling before dissection.
We found that the decreases in NR2A, NR2B, and NR1 were
present in both OFC and mPFC of the behaviorally naive Fmr1
KO mice, suggesting that these changes precede the cognitive
impairments observed in the mice (Table 1). Similarly, SAPAP3,
PSD-95, and Arc were decreased basally in OFC of Fmr1 KO
mice, but not in mPFC, consistent with data from behaviorally
trained mice. Conversely, the control proteins SNAP25 and actin
were not signiﬁcantly changed. These data imply that the mo-
lecular alterations described in this study are a direct consequence
of the loss of FMRP expression in the PFC and may in turn
contribute to cognitive dysfunction in the Fmr1 KO mice.
Synaptic Proteins Are Altered in Synaptoneurosomes from Be-
haviorally Naive Fmr1 KO Mice. To conﬁrm that the changes ob-
served in the whole-homogenate preparation reﬂect alterations in
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Fig. 2. Expression of proteins related to synaptic function is decreased in
OFC and mPFC of Fmr1 KO mice. (A) Schematic illustrating the brain regions
dissected for biochemical analysis [brain-slice images adapted from the
Mouse Brain Library (42)]. (B) Representative blot showing staining for total
protein levels in OFC of WT and KO mice. No major differences were ob-
served in the pattern of protein bands in Fmr1 KO mice. “Std,” standard.
Numbers represent the molecular weight in kilodaltons of the standard
bands. (C) Representative immunoblots from OFC of WT and KO mice for
each of the proteins included in D and E. Quantiﬁcation of protein levels in
OFC (D) and mPFC (E) of WT and KO mice (n = 18–24). Signiﬁcant decreases
were observed in a number of proteins in Fmr1 KOmice. Error bars represent
SEM; *P < 0.05, **P < 0.01, ***P < 0.001.
Table 1. Expression of proteins associated with postsynaptic
function is reduced in both homogenate and
synaptoneurosomes of Fmr1 KO mice
Trained
(homogenate)
Naive
(homogenate) Naive (SNS)
% WT n P value % WT n P value % WT n P value
OFC
NR1 85.5 22 0.003 90.6 22 <0.001 92.7 22 0.026
NR2A 82.1 20 <0.001 88.6 23 0.006 82.9 21 <0.001
NR2B 97.0 21 0.647 88.3 24 0.019 85.6 22 0.003
SAPAP3 84.5 22 <0.001 85.9 23 0.036 86.1 22 0.012
PSD95 86.2 22 0.017 90.2 29 0.026 91.9 22 0.048
Arc 89.2 22 0.004 91.8 22 0.033 91.1 16 0.032
SNAP25 97.9 22 0.593 102.5 22 0.449 95.3 24 0.249
Actin 103.1 23 0.494 104.5 23 0.547 104.1 22 0.806
mPFC
NR1 89.7 23 0.025 90.4 21 0.024 87.0 22 <0.001
NR2A 88.8 22 0.015 86.3 22 0.004 86.6 22 <0.001
NR2B 85.8 22 0.012 85.8 23 0.025 86.8 21 0.013
SAPAP3 89.4 22 0.015 87.3 23 0.019 90.8 21 0.107
PSD95 93.4 22 0.100 94.9 23 0.308 99.4 23 0.915
Arc 95.6 22 0.447 96.9 20 0.342 99.3 16 0.882
SNAP25 104.2 23 0.290 97.6 27 0.438 94.5 22 0.160
Actin 103.9 18 0.683 97.1 20 0.687 99.2 22 0.763
For each protein, data are expressed as percentage of WT levels in Fmr1
KO. n represents the number of animals per group. Signiﬁcance was deter-
mined by paired Student’s t test.
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receptor composition at individual synapses, we repeated our
molecular analysis using a synaptoneurosome (SNS) preparation
that is enriched in pre- and postsynaptic structures (25). SNS were
prepared from the same set of behaviorally naive WT and Fmr1
KO mice used for the whole-homogenate preparation. We found
that the expression pattern of NR1, NR2A, NR2B, PSD-95,
SAPAP3, and Arc was virtually the same in SNS and in whole-
homogenate samples (Table 1), implying that these changes re-
ﬂect alterations in the complexity of individual synapses.
Levels of c-Fos Expression Are Decreased Basally in OFC and mPFC of
Fmr1 KO Mice. In light of our ﬁndings that synaptic protein
composition is altered basally in OFC and mPFC of Fmr1 KO
mice, we investigated whether these changes are accompanied by
differences in the basal expression of c-Fos, a marker used to
assess neuronal activity (26). Sections were prepared from OFC
and mPFC of WT and Fmr1 KO mice, and they were then an-
alyzed for expression of c-Fos and the neuronal marker NeuN by
immunohistochemistry (Fig. 4A). Our data revealed that the
percentage of c-Fos–expressing neurons was signiﬁcantly lower
in Fmr1 KO mice than in WT mice both in OFC (Fig. 4B; P <
0.05) and in mPFC (Fig. 4C; P < 0.05). These data suggest that
neuronal activity is decreased basally in the PFC of Fmr1 KO
mice, which is likely to contribute to the other phenotypes de-
scribed in this study.
Discussion
In the present study, we report the identiﬁcation of a robust
cognitive deﬁcit in the Fmr1 KO mouse model of FXS, as well as
accompanying changes in synaptic composition and neuronal
activity in the PFC of Fmr1 KO mice. Our ﬁndings have two
important implications. First, the behavioral task developed here
provides a tool to screen drug candidates for efﬁcacy in treating
the impairments in higher cognitive function that are central to
FXS. Second, the observation that postsynaptic proteins, and
particularly NMDA receptor subunits, are decreased in the PFC
of adult Fmr1 KO mice contributes signiﬁcantly to our un-
derstanding of the molecular mechanisms by which loss of
FMRP expression may cause cognitive dysfunction.
The development of reliable behavioral paradigms that can be
used to model the symptoms of neurodevelopmental disorders
such as FXS and autism in mouse models is important for the
validation of new therapeutics (27). A number of behavioral
assays have been used to study the efﬁcacy of putative treatment
strategies in Fmr1 KO mice, including tests of anxiety, suscepti-
bility to seizures, sensorimotor gating, sociability, and fear
memory (7, 13, 28, 29). On the basis of these assays, exciting
insights have been gained regarding the potential for developing
small molecule therapeutics for FXS. However, none of these
studies to date have directly addressed the higher cognitive phe-
notypes that are the hallmark features of FXS, partly due to
a paucity of suitable animal models. Given that these phenotypes
are likely to have molecular substrates and developmental tra-
jectories that are very different from those for behavioral traits
such as anxiety and sociability, it will be essential to establish
whether results obtained from tests of the latter can be general-
ized. Our study aimed to provide a measure of cognitive dys-
function in Fmr1 KO mice for this purpose. We found that Fmr1
KO mice are not impaired in the acquisition of an appetitive in-
strumental response, consistent with a previous report (30). In
contrast, Fmr1 KO mice were signiﬁcantly impaired in the sub-
sequent acquisition of a visuospatial discrimination in a manner
that is consistent with an inability either to ﬂexibly respond to
changing reward contingencies or to shift attention from one
perceptual dimension (spatial location) to another (visual cue).
Both of these cognitive skills are impaired in individuals with FXS
(31, 32), and both have been linked to the PFC (22, 23). It is
therefore likely that the behavioral phenotype identiﬁed here
reﬂects a deﬁcit in PFC function in the Fmr1 KO mice, providing
a useful paradigm for further research in this area.
In accordance with this assumption, signiﬁcant decreases were
observed in a number of synapse-associated proteins in the OFC
and mPFC of Fmr1 KO mice. This ﬁnding was initially surprising
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Fig. 4. c-Fos expression is decreased in OFC and mPFC of Fmr1 KO mice. (A)
Representative image of c-Fos and NeuN staining in OFC of WT (Left) and KO
(Right) mice. (B and C) Quantiﬁcation of the number of c-Fos–positive
neurons (normalized to the total number of neurons per image and
expressed as percentage of WT levels) in OFC (B) and mPFC (C) of WT and KO
mice. A signiﬁcant reduction in the number of c-Fos–positive neurons was
observed in both OFC (paired Student’s t test, P < 0.05, n = 8) and mPFC (P <
0.05, n = 8). Error bars represent SEM; *P < 0.05.
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because FMRP is thought to be a translational repressor, the
absence of which should cause levels of target proteins to in-
crease rather than decrease (6, 7). Indeed, several of the proteins
identiﬁed here are known to be directly or indirectly regulated by
FMRP, including NR2A (33), SAPAP3 (15, 34), PSD-95 (35),
and Arc (36), and previous studies have reported that, under
different conditions, these proteins are either increased or un-
altered (15, 34, 37, 38). It is likely that the decreases observed in
our study reﬂect an impoverished postsynaptic architecture due
to long-term developmental alterations at synapses in the pre-
frontal cortex, rather than an acute effect of the loss of FMRP-
mediated translational regulation. This theory is consistent with
reports of an increased density of long ﬁlopodial-like spines in the
PFC of Fmr1 KOmice (13, 14), which are likely to contain a more
immature, and hence less complex, postsynaptic apparatus. In-
terestingly, the decrease in levels of the NMDA receptor subunits
NR2A and, to a lesser extent, NR2B in the mPFC appears to be
especially relevant for the cognitive impairments observed here.
Although the details of the relationship between NR2A/B levels
and behavioral performance have yet to be determined, it is in-
teresting to note that both cognitive ﬂexibility and attentional
shifting are dependent on NMDA receptor function and can be
impaired by pharmacological antagonism of NMDA receptors (39,
40). Similarly, levels of SAPAP3 were consistently decreased in
both regions of PFC. Given that loss of SAPAP3 in mice has pre-
viously been linked to aberrations at corticostriatal synapses and
repetitive behavioral phenotypes reminiscent of obsessive-com-
pulsive disorder (41), it is possible that the changes in SAPAP3
levels observed here may also partly contribute to the cognitive
phenotype in the Fmr1 KO mice.
Parallel to the alterations in synaptic composition, we also
observed a decrease in the percentage of c-Fos–positive neurons
in both OFC and mPFC of Fmr1 KOmice, indicating a reduction
in basal neuronal activity. Interestingly, a recent study showed
that spike-timing–dependent plasticity is altered inmPFC of Fmr1
KO mice due to a reduction in L-type calcium channel function
and decreased reliability of postsynaptic calcium signaling (14). It
is conceivable that the same developmental processes that result
in the impoverished synaptic architecture identiﬁed above may
also affect expression of L-type calcium channels, which in turn
may contribute to the decreased c-Fos expression and neuronal
activation observed in our study. Overall, it thus appears that loss
of FMRP function leads to reduction of synaptic and neuronal
function at multiple levels, and that in combination, these alter-
ations may result in substantial cognitive impairments such as the
one identiﬁed in our study. By inference, similar molecular and
cellular abnormalities could potentially underlie human pheno-
types believed to be associated with PFC dysfunction—most no-
tably the perseverative behaviors and restricted interests that are
a hallmark of FXS and autism.
Materials and Methods
Subjects. Male Fmr1 KO mice (The Jackson Laboratory) and WT littermates
were bred on a C57BL/6 background and used for experiments at age 2–4
mo (see SI Materials and Methods for details). In all experiments, yoked WT-
KO pairs that were processed simultaneously and under identical conditions
were used. Experimenters were blind to genotype at all times throughout
the experiment. All experiments were approved by the Massachusetts In-
stitute of Technology Committee on Animal Care and followed the National
Institutes of Health Guide for the Care and Use of Laboratory Animals.
Behavioral Training. Behavioral experiments were conducted in operant
conditioning chambers (Med Associates) equipped with ﬁve nose-poke
apertures and a pellet dispenser and foodmagazine. Before each experiment,
mice were food-restricted to 85% free-feeding body weight and given two
daily magazine training sessions, each lasting 10min, in which each entry into
the food magazine was reinforced by one food pellet. Subsequently, mice
were trained on one of two behavioral experiments (1): a 5CSRTT (see SI
Materials and Methods for details) or (2) a visuospatial discrimination task
derived from the training phase of the 5CSRTT.
For the visuospatial discrimination task, mice (n = 14 pairs) were trained in
two phases to perform a nose-poke response to a visual cue.
Phase 1. In this phase, all ﬁve nose-poke apertures were illuminated and
active, and mice were trained on an instrumental response in daily 15-min
sessions. Each trial began with the illumination of the apertures, and a re-
sponse in any aperture resulted in delivery of a food reward (“correct re-
sponse”). At this time, the lights in the apertures were turned off and the
magazine light was turned on. A trial was considered completed when the
food pellet was retrieved, at which time the magazine light was turned off
and the aperture lights were turned back on. Mice were required to com-
plete at least 15 trials per session for two consecutive days (“criterion”) to
advance to the next training phase.
Phase 2. This phase was identical to the previous phase, except that only one
nose-poke aperture was illuminated and active at any given time. A response
in this aperture resulted in delivery of a food reward (“correct response”),
whereas a response in any other aperture had no programmed consequence
(“error”). For each trial, a different nose-poke aperture was chosen to be
illuminated and active in a pseudorandomized manner. Mice reached cri-
terion for this phase when they completed >15 trials per session and made
more correct responses than errors (i.e., >50% accuracy rate) for two con-
secutive days. Data were recorded as the number of days to criterion, the
cumulative number of errors to criterion, the number of trials per day, and
the number of errors per trials performed across days of training.
Tissue Preparation for Biochemical Analysis. Behaviorally trained mice (n = 26
pairs) were killed 24 h after the last behavioral training session, and whole-
homogenate samples from OFC and mPFC were isolated. Behaviorally naive
mice (n = 25–30 pairs) were killed without any prior handling, and tissue
homogenates and synaptoneurosomes were prepared using a protocol
modiﬁed from Hollingsworth et al. (25). See SI Materials and Methods
for details.
Immunoblotting. Protein levels in whole homogenate and SNS were de-
termined using standard immunoblotting procedures. Each lane contained 5–
10 μg total protein because this amount of total protein was found to yield
signals in the linear range for our target proteins (Fig. S2). See SI Materials
and Methods for further details.
Immunohistochemistry. Mice (n = 8 pairs) were transcardially perfused with
4% paraformaldehyde, and 50-μm brain sections were stained for c-Fos and
NeuN by using standard immunohistochemistry procedures. Images were
acquired with an Olympus laser-scanning confocal microscope, and image
analysis was conducted on raw images using ImageJ software. See SI
Materials and Methods for further details.
Statistical Analysis. Statistical analysis for behavioral experiments was con-
ducted using one-way or two-way repeated measures ANOVA, and post hoc
analysis was performed using Scheffé’s test. Group comparisons for the
biochemical analysis were conducted using two-tailed paired Student’s t
tests. Relationships between behavioral data and protein levels were ana-
lyzed using Pearson’s correlation coefﬁcient. See SI Materials and Methods
for further details.
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